Trading News | Page: 2 | IFCM India
IFC Markets Online CFD Broker

Trading News

HSBC 2024 Earnings In

HSBC 2024 Earnings In

HSBC Holdings (LON: HSBA) delivered earnings report for 2024. While the bank’s restructuring efforts are aggressive, traders should be aware of the near-term risks—falling interest rates, costly layoffs,...

20/2/2025
Gold Market News: How Tariffs and Fed Decisions Impact Prices

Gold Market News: How Tariffs and Fed Decisions Impact Prices

Gold prices held firm near record levels on Wednesday as investors weighed escalating trade tensions sparked by U.S. President Donald Trump’s tariff plans against potential shifts in Federal Reserve...

19/2/2025
HSBC: Cost-Cutting Win or Strategic Mistake

HSBC: Cost-Cutting Win or Strategic Mistake

HSBC's decision to shut down parts of its investment banking division has divided opinions. On one hand, investors are cheering the move as a disciplined shift toward profitability. On the other, HSBC...

17/2/2025
Barrick Gold Forecasts a 30% Production Increase by 2030

Barrick Gold Forecasts a 30% Production Increase by 2030

Barrick Gold (NYSE: GOLD) remains a key player in the gold mining sector, but for traders, the focus isn’t just on long-term fundamentals—it’s on price action, volatility, and potential catalysts...

13/2/2025
Tech Giants Invest Billions in AI for Long-Term Growth

Tech Giants Invest Billions in AI for Long-Term Growth

Tech giants are ramping up AI investments, signaling a serious commitment to an AI-driven future. Microsoft, Google (Alphabet), Meta Platforms, and Amazon are spending tens of billions on data centers...

7/2/2025
Toyota Q3 Profit Increases, But Operating Income Falls Short

Toyota Q3 Profit Increases, But Operating Income Falls Short

Toyota Motor Corp (TYO:7203) reported better-than-expected profit for the December quarter, helped by demand for hybrid vehicles and favorable exchange rates. Net profit for the quarter ended Dec. 31 rose...

5/2/2025
Can Novo Nordisk Keep Up with Eli Lilly?

Can Novo Nordisk Keep Up with Eli Lilly?

Novo Nordisk, long dominant in the obesity drug market with its blockbuster Wegovy, is facing a challenge. Its highly anticipated next-generation drug, CagriSema, was meant to counter Eli Lilly’s surging...

4/2/2025
Starbucks (SBUX) Beats Q1 Estimates, But Is It Justified?

Starbucks (SBUX) Beats Q1 Estimates, But Is It Justified?

Starbucks (SBUX) posted a modest earnings beat in its first-quarter report for fiscal 2025, delivering $0.69 per share versus the consensus estimate of $0.66. A 4.55% surprise might look encouraging at...

29/1/2025
DeepSeek Raises Questions

DeepSeek Raises Questions

Yesterday, we saw a significant selloff in the tech market, largely driven by the rise of DeepSeek, a Chinese AI assistant that's challenging the dominance of U.S. companies. What’s catching investors'...

28/1/2025
Close support
Call to WhatsApp Call to telegram Call Back